Chronic Kidney Disease: From Early Detection to Modern Management Strategies
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Urology & Nephrology".
Deadline for manuscript submissions: 10 April 2026 | Viewed by 9
Special Issue Editor
2. Department of Nephrology, Policlinico University, 56121 Pisa, Italy
Interests: clinical nephrology; immunology; modern pharmacological approach; chronic kidney disease
Special Issue Information
Dear Colleagues,
In recent years, the treatment of chronic kidney disease (CKD) has become a priority in light of its impact on public health: a 7.7% increase is expected in CKD incidence by 2032. Recently, there has been a radical shift in focus from approaches on risk factor prevention to interventions in disease cases. Newly introduced therapies, such as SGLT2 inhibitors and non-steroidal MRIs, aim to reduce the progression of chronic kidney disease and prevent end-stage kidney disease as their clinical impacts. The benefits are evident in all stages of kidney disease and will produce benefits over time including a reduced need for dialysis, a reduced need for transplants and reductions in costs. Therefore, from this perspective, it is essential to stratify patients who would benefit from optimizing nephroprotective treatment as early on in the disease course as possible. The aim of this Special Issue is to explore these aspects, looking at past developments, focusing on present progress and looking towards possible future advancements in reducing the progression of CKD and improving long-term outcomes. Original papers, experimental papers, and reviews will be considered and reviewed for the Special Issue.
Dr. Domenico Giannese
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- proteinuria
- chronic kidney disease
- SGLT2-I
- management of CKD
- nephroprotection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
